全文获取类型
收费全文 | 984篇 |
免费 | 72篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 19篇 |
妇产科学 | 29篇 |
基础医学 | 98篇 |
口腔科学 | 35篇 |
临床医学 | 83篇 |
内科学 | 225篇 |
皮肤病学 | 32篇 |
神经病学 | 102篇 |
特种医学 | 14篇 |
外科学 | 139篇 |
综合类 | 17篇 |
预防医学 | 93篇 |
眼科学 | 2篇 |
药学 | 66篇 |
1篇 | |
中国医学 | 3篇 |
肿瘤学 | 106篇 |
出版年
2023年 | 10篇 |
2022年 | 22篇 |
2021年 | 20篇 |
2020年 | 20篇 |
2019年 | 16篇 |
2018年 | 33篇 |
2017年 | 16篇 |
2016年 | 18篇 |
2015年 | 26篇 |
2014年 | 21篇 |
2013年 | 42篇 |
2012年 | 70篇 |
2011年 | 53篇 |
2010年 | 33篇 |
2009年 | 40篇 |
2008年 | 39篇 |
2007年 | 68篇 |
2006年 | 45篇 |
2005年 | 52篇 |
2004年 | 44篇 |
2003年 | 48篇 |
2002年 | 30篇 |
2001年 | 37篇 |
2000年 | 30篇 |
1999年 | 38篇 |
1998年 | 22篇 |
1997年 | 8篇 |
1996年 | 5篇 |
1995年 | 5篇 |
1994年 | 4篇 |
1993年 | 3篇 |
1992年 | 15篇 |
1991年 | 14篇 |
1990年 | 8篇 |
1989年 | 7篇 |
1988年 | 8篇 |
1987年 | 10篇 |
1986年 | 11篇 |
1985年 | 11篇 |
1984年 | 3篇 |
1983年 | 9篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1980年 | 6篇 |
1979年 | 5篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1970年 | 4篇 |
1966年 | 4篇 |
1965年 | 3篇 |
排序方式: 共有1066条查询结果,搜索用时 31 毫秒
221.
Arancio M Ranzoni S Delsignore A Maffei N Landi G Mina A Marcato M Martinengo C 《Urologia》2010,77(4):263-266
Low grade fibromyxoid sarcoma is an uncommon soft tissue tumor. We present the case of a 83-year-old female who developed large mass in the right kidney. A nephrectomy was performed. The tumor measured 18,5x17,5x11,5 cm and on pathology evaluation was diagnosed as low grade fibromyxoid sarcoma. Currently, the patient is doing well without evidence of local recurrence and distant metastasis. Low grade fibromyxoid sarcoma of the Kidney is a very rare tumor. The metastasizing potential is high. Sometimes long interval between tumor presentation and metastasis is observed. The treatment of choice is surgery. The role of radiotherapy and chemotherapy is uncertain. 相似文献
222.
Carmelo Luigiano Francesco Ferrara Stefania Ghersi Carlo Fabbri Vincenzo Cennamo Patrizia Landi Anna Maria Polifemo Paola Billi Marco Bassi Pierluigi Consolo Angela Alibrandi Nicola D’Imperio 《Digestive diseases and sciences》2010,55(6):1726-1731
Background
The most common complication of polypectomy is hemorrhage, and various techniques have been used to prevent this complication.Aim
This study evaluates the outcomes of endoclip-assisted polypectomy in patients with large pedunculated colorectal polyps, in comparison with a historical control group of patients treated with endoloop-assisted polypectomy.Methods
Between January and December 2007, 32 patients with 32 large pedunculated polyps (≥15 mm) were treated with endoclip-assisted polypectomy (group A). Between January and December 2006, 35 patients with 35 large pedunculated polyps were treated; 33 with endoloop-assisted polypectomy (control, group B) and two cases with endoclips and needle knife, which were included in group A for the analysis.Results
The mean (± standard deviation [SD]) size of polyp head was 26.8 ± 8.1 mm (range 15–50) in group A and 22.3 ± 4.1 mm (range 15–30) in group B (P = 0.004). In group A, six polyps had a mean (±SD) head size of 40.8 ± 5.8 mm (range 35–50) and were resected with clips and needle knife. In group A, bleeding occurred in two cases (5.9%), which were associated with the presence of cancer at histology (P = 0.006) and were managed by applying new clips. No bleeding occurred in patients of group B and no perforation and post-polypectomy syndrome occurred in either group. There were three (8.8%) cancerized adenomas in group A and one (3%) in group B. Clip application was possible in all patients, while in two cases, loop placement was impossible.Conclusions
In our experience, endoclip-assisted resection is a safe alternative to endoloop for the resection of large pedunculated colorectal polyps when endoloop placement is difficult or impossible. 相似文献223.
HDL-cholesterol and physical performance: results from the ageing and longevity study in the sirente geographic area (ilSIRENTE Study) 总被引:1,自引:0,他引:1
BACKGROUND: High-density lipoprotein (HDL) cholesterol has been hypothesised to be a reliable marker of frailty and poor prognosis among the oldest elderly. We evaluate the relationship of HDL-cholesterol with measures of physical performance, muscle strength, and functional status in older persons aged 80years or older. METHODS: Data are from baseline evaluation of the ageing and longevity study in the Sirente geographic area (ilSIRENTE study) (n = 364). Physical performance was assessed using the physical performance battery score [short physical performance battery (SPPB)], which is based on three-timed tests: 4-m walking-speed, balance, and chair-stand tests. Muscle strength was measured by hand-grip strength. Analyses of covariance were performed to evaluate the relationship of different HDL-cholesterol levels with physical function. RESULTS: In the unadjusted analyses, physical function (as measured by the 4-m walking-speed, theSPPB score, the basic and instrumental activities of daily living scales scores), but not hand-grip strength, improved significantly as HDL-cholesterol tertiles increased. After adjustment for potential confounders, which included age, gender, living alone, alcohol abuse, physical activity, congestive heart failure, diabetes, cerebrovascular diseases, osteoarthritis, albumin, urea, C-reactive protein and LDL cholesterol, the association of HDL-cholesterol tertiles with the 4-m walking-speed and the SPPB score was still consistent. CONCLUSION: The present study suggests that among very old subjects living in the community the higher levels of HDL-cholesterol are associated with better functional performance. 相似文献
224.
Association between increased mortality and mild thyroid dysfunction in cardiac patients 总被引:1,自引:0,他引:1
Iervasi G Molinaro S Landi P Taddei MC Galli E Mariani F L'Abbate A Pingitore A 《Archives of internal medicine》2007,167(14):1526-1532
BACKGROUND: The effects of subclinical thyroid dysfunction on cardiac outcome are not well defined. METHODS: To assess the relationship between mild thyroid dysfunction and the incidence of death in cardiac patients, we evaluated 3121 cardiac patients. Cardiac and overall deaths were considered. Four groups were defined: euthyroidism, subclinical hypothyroidism (SCH), subclinical hyperthyroidism (SCT), and low triiodothyronine syndrome (low T3). RESULTS: After mean follow-up of 32 months, there were 65 and 140 cardiac and overall deaths (3.4% and 7.3%), respectively, in euthyroidism, 15 and 27 (7.2% and 13.0%) in SCH, 8 and 9 (8.2% and 9.2%) in SCT, and 59 and 119 (6.5% and 13.1%) in low T3. Survival rates for cardiac death were lower in SCH, SCT, and low T3 than in euthyroidism (log-rank test; chi2 = 19.46; P < .001). Survival rates for overall death were lower in SCH and low T3 than in euthyroidism (log-rank test; chi2 = 26.67; P < .001). After adjustment for several risk factors, hazard ratios (HRs) for cardiac death were higher in SCH (HR, 2.40; 95% confidence interval [CI], 1.36-4.21; P = .02), SCT (HR, 2.32; 95% CI, 1.11-4.85; P = .02), and low T(3) (HR, 1.63; 95% CI, 1.14-2.33; P = .007) than in euthyroidism; HRs for overall death were higher in SCH (HR, 2.01; 95% CI, 1.33-3.04; P < .001) and low T3 (HR, 1.57; 95% CI, 1.22-2.01; P < .001) but not in SCT. CONCLUSION: A mildly altered thyroid status is associated with an increased risk of mortality in patients with cardiac disease. 相似文献
225.
Banu E Banu A Fodor A Landi B Rougier P Chatellier G Andrieu JM Oudard S 《Drugs & aging》2007,24(10):865-879
OBJECTIVE: To evaluate the impact on overall survival at 6, 12 and 18 months of gemcitabine-based doublets compared with gemcitabine alone in patients with advanced and metastatic pancreatic cancer. METHODS: We conducted a systematic review and meta-analysis of published data on the use of gemcitabine-based doublets compared with gemcitabine alone in chemotherapy-naive patients with advanced and metastatic pancreatic cancer treated in randomised controlled phase II-III trials with overall survival as the principal or secondary endpoint. To this end, a literature search was performed using Cochrane methodology. The relative risks with 95% confidence intervals were estimated based on adjusted number of deaths and patients at risk according to the extent of follow-up and censoring. Twenty-three randomised clinical trials including 5886 patients met the inclusion criteria. In these trials, 2932 patients were randomly assigned to receive gemcitabine-based doublets and 2954 patients to receive gemcitabine alone. RESULTS: Gemcitabine-based doublets were associated with small but significant reductions in the risk of death at 6, 12 and 18 months of 8% (95% CI 3, 13), 4% (95% CI 2, 7) and 3% (95% CI 1, 5), respectively (p<0.005 for all timepoints). No heterogeneity between studies was observed. Subgroup analyses showed an overall survival benefit for gemcitabine-based doublets in clinical trials testing the same planned dose intensity of gemcitabine in comparative arms, using platinum salt-based protocols and with survival as the primary endpoint. CONCLUSION: This meta-analysis of data obtained from randomised controlled phase II-III trials of patients with advanced pancreatic cancer showed a small but significant improvement in overall survival for patients receiving gemcitabine-based doublets compared with gemcitabine alone. 相似文献
226.
Siquini W Stortoni P Criante P Mazzucchelli R Angelici S Romiti M Fianchini A Landi E 《Chirurgia italiana》2007,59(4):559-563
Carcinoid tumours are known to occur frequently in the gastrointestinal and respiratory tracts. A primary carcinoid tumour of the kidney is an extremely rare entity and only 40 cases have been reported in the literature. As a consequence, very little is known about its real histogenesis, and its prognosis and clinicopathological patterns are not precisely defined. We report a case of primary carcinoid tumour of the kidney found in a middle-aged woman treated by nephrectomy, along with a thorough review of the literature concerning this kind of neoplasm. 相似文献
227.
Microbial biomass, respiration and enzyme activities after in situ aided phytostabilization of a Pb- and Cu-contaminated soil 总被引:1,自引:0,他引:1
Kumpiene J Guerri G Landi L Pietramellara G Nannipieri P Renella G 《Ecotoxicology and environmental safety》2009,72(1):115-119
We conducted a pilot-scale experiment to study the effects of an aided phytostabilisation on soil microbial and biological endpoints in an ore dust-contaminated soil. Soil was amended with alkaline fly ashes plus peat to reduce mobility of trace elements and vegetated with a proprietary grass/herb mixture. Results indicated that the proposed aided phytostabilization approach of Cu-Pb contaminaed soil significantly increased microbial biomass and respiration, reduced microbial stress and increased key soil enzyme activities. Further research is needed to unambiguously determine whether the soil biochemical endpoints that were studied responded more to decreased metal mobility or to general soil amelioration. 相似文献
228.
Sergio G Chialina Claudia Fornes Carolina Landi Carlos D de La Vega Elena Maria V Nicolorich Ricardo J Dourisboure Angela Solano Edita A Solis 《BMC medical genetics》2006,7(1):5-5
Background
Hereditary non-polyposis colon cancer (HNPCC) is an autosomal dominant syndrome predisposing to the early development of various cancers including those of colon, rectum, endometrium, ovarium, small bowel, stomach and urinary tract. HNPCC is caused by germline mutations in the DNA mismatch repair genes, mostly hMSH2 or hMLH1. 相似文献229.
230.
Emile JF Brahimi S Coindre JM Bringuier PP Monges G Samb P Doucet L Hostein I Landi B Buisine MP Neuville A Bouché O Cervera P Pretet JL Tisserand J Gauthier A Le Cesne A Sabourin JC Scoazec JY Bonvalot S Corless CL Heinrich MC Blay JY Aegerter P 《Medical oncology (Northwood, London, England)》2012,29(3):1765-1772
Gastrointestinal stromal tumors (GISTs) are the most common human sarcoma. Most of the data available on GISTs derive from retrospective studies of patients referred to oncology centers. The MolecGIST study sought to determine and correlate clinicopathological and molecular characteristics of GISTs. Tumor samples and clinical records were prospectively obtained and reviewed for patients diagnosed in France during a 24-month period. Five hundred and ninety-six patients were included, of whom 10% had synchronous metastases. GISTs originated from the stomach, small bowel or other site in 56.4, 30.2 and 13.4% of cases, respectively. The main prognostic markers, tumor localization, size and mitotic index were not independent variables (P < 0.0001). Mutational status was determined in 492 (83%) patients, and 138 different mutations were identified. KIT and PDGFRA mutations were detected in 348 (71%) and 74 (15%) patients, respectively, contrasting with 82.8 and 2.1% in patients with advanced GIST (MetaGIST) (P < 0.0001). Further comparison of localized GISTs in the MolecGIST cohort with advanced GISTs from previous clinical trials showed that the mutations of PDGFRA exon18 (D842V and others) as well as KIT exon11 substitutions (W557R and V559D) were more likely to be seen in patients with localized GISTs (odds ratio 7.9, 3.1, 2.7 and 2.5, respectively), while KIT exon 9 502_503dup and KIT exon 11 557_559del were more frequent in metastatic GISTs (odds ratio of 0.3 and 0.5, respectively). These data suggest that KIT and PDGFRA mutations and standardized mitotic count deserve to be investigated to evaluate the relapse risk of GISTs. 相似文献